IKKβ Deficiency in Myeloid Cells Ameliorates Alzheimer's Disease-Related Symptoms and Pathology
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is characterized by extracellular amyloid-β (Aβ) deposits and microglia-dominated inflammatory activation. Innate immune signaling controls microglial inflammatory activities and Aβ clearance. However, studies examining innate immunity in Aβ pathology and neuronal degeneration have produced conflicting results. In this study, we investigated the pathogenic role of innate immunity in AD by ablating a key signaling molecule, IKKβ, specifically in the myeloid cells of TgCRND8 APP-transgenic mice. Deficiency of IKKβ in myeloid cells, especially microglia, simultaneously reduced inflammatory activation and Aβ load in the brain and these effects were associated with reduction of cognitive deficits and preservation of synaptic structure proteins. IKKβ deficiency enhanced microglial recruitment to Aβ deposits and facilitated Aβ internalization, perhaps by inhibiting TGF-β-SMAD2/3 signaling, but did not affect Aβ production and efflux. Therefore, inhibition of IKKβ signaling in myeloid cells improves cognitive functions in AD mice by reducing inflammatory activation and enhancing Aβ clearance. These results contribute to a better understanding of AD pathogenesis and could offer a new therapeutic option for delaying AD progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611 · cited 1×
“We also measured A levels in the plasma and the expression of RAGE and LRP1 in the brain, two receptors that act as shuttles to transport A across the blood– brain barrier (Shibata et al., 2000; Deane et al., 2003 and 2004).”
MethodOligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · cited 1×
“We also measured A levels in the plasma and the expression of RAGE and LRP1 in the brain, two receptors that act as shuttles to transport A across the blood– brain barrier (Shibata et al., 2000; Deane et al., 2003 and 2004).”
MethodMicroglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 1×
“7E; one-way ANOVA, p 0.05), a finding consistent with the observations of El Khoury’s group (Hickman et al., 2008).”
ResultInfluentialBeta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089 · cited 3×
“Brain macrophages have been shown to originate from CCR2 monocytes (Mildner et al., 2007; Varvel et al., 2012).”
BackgroundResultIn-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · cited 1×
“Positron emission tomography studies have shown that microglial activation correlates with disease progression in AD patients (Cagnin et al., 2001; Edison et al., 2008; Okello et al., 2009).”
BackgroundNeurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000 · cited 3×
“Deficiency of IKK in myeloid cells (microglia) reduces A load in aged APP-transgenic mouse brains Because A pathology is considered to be the key mechanism mediating neuronal death in AD (Mucke and Selkoe, 2012), we continued to investigate the effects on the cerebral A load of IKK deficiency in myeloid cells.”
BackgroundMethodRapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987 · cited 1×
“In AD mouse models, which overexpress Alzheimer’s APP in neurons, microglia are observed to be activated and recruited to deposits of pathogenic amyloid peptides (A ) (Bolmont et al., 2008; Meyer-Luehmann et al., 2008).”
BackgroundInflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975 · cited 2×
“M1 inflammatory activation contributes to neuronal degeneration (Akiyama et al., 2000; Wyss-Coray and Rogers, 2012).”
BackgroundChishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · cited 1×
“In this mouse strain, the A load does not differ between male and female mice (Chishti et al., 2001).”
BackgroundA new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
Goldmann, T., Wieghofer, P., Müller, P. F., Wolf, Y., Varol, D., Yona, S., Brendecke, S. M., Kierdorf, K., Staszewski, O., Datta, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3531 · Cited by 688
Saederup, N., Cardona, A. E., Croft, K., Mizutani, M., Cotleur, A. C., Tsou, C.-L., Ransohoff, R. M., & Charo, I. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013693 · Cited by 599 · cited 2×
“We cross-bred TgCRND8 APP-transgenic mice to CCR2RFP mice (Saederup et al., 2010).”
BackgroundMethodDynamics of the Microglial/Amyloid Interaction Indicate a Role in Plaque Maintenance
Bolmont, T., Haiss, F., Eicke, D., Radde, R., Mathis, C. A., Klunk, W. E., Kohsaka, S., Jucker, M., & Calhoun, M. E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-07.2008 · Cited by 526
Edison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513 · cited 1×
“Positron emission tomography studies have shown that microglial activation correlates with disease progression in AD patients (Cagnin et al., 2001; Edison et al., 2008; Okello et al., 2009).”
BackgroundRole of toll-like receptor signalling in A uptake and clearance
Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2006) · Brain · doi:10.1093/brain/awl249 · Cited by 493 · cited 4×
“deposition (Tahara et al., 2006), whereas another study showed”
BackgroundResultInfluentialTLR2 Is a Primary Receptor for Alzheimer’s Amyloid β Peptide To Trigger Neuroinflammatory Activation
Liu, S., Liu, Y., Hao, W., Wolf, L., Kiliaan, A. J., Penke, B., Rübe, C. E., Walter, J., Heneka, M. T., Hartmann, T., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101121 · Cited by 439 · cited 18×
“…M2 inflammatory activation appears to produce ben- eficial effects in AD by facilitating neurotoxic inflammatory resolution and promoting neuronal protection and regeneration (Colton et al., 2006; Qian et al., 2006; Martinez et al., 2009; Ma et al., 2010; Sharma et al., 2011; Liu et al., 2012).”
BackgroundMethodResultInfluentialSelf-citationBlocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology
Town, T., Laouar, Y., Pittenger, C., Mori, T., Szekely, C. A., Tan, J., Duman, R. S., & Flavell, R. A. (2008) · Nature Medicine · doi:10.1038/nm1781 · Cited by 422 · cited 7×
“Inhibition of TGF- -SMAD2/3 signaling could be involved in microglial A internalization enhanced by IKK deficiency Because it has been reported that blocking either CD40 or the TGF- signaling cascade in AD mice leads to a reduction in both inflammatory activation and A load in the brain (Tan et al., 1999 and 2002; Tow…”
BackgroundMethodInfluentialInhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
vom Berg, J., Prokop, S., Miller, K. R., Obst, J., Kälin, R. E., Lopategui-Cabezas, I., Wegner, A., Mair, F., Schipke, C. G., Peters, O., et al. (2012) · Nature Medicine · doi:10.1038/nm.2965 · Cited by 416
Hawkes, C. A., & McLaurin, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805453106 · Cited by 397
Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.
(2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-27 · Cited by 393 · cited 5×
“…M2 inflammatory activation appears to produce ben- eficial effects in AD by facilitating neurotoxic inflammatory resolution and promoting neuronal protection and regeneration (Colton et al., 2006; Qian et al., 2006; Martinez et al., 2009; Ma et al., 2010; Sharma et al., 2011; Liu et al., 2012).”
BackgroundMethodInfluentialDeane, R., Wu, Z., & Zlokovic, B. V. (2004) · Stroke · doi:10.1161/01.str.0000143452.85382.d1 · Cited by 392 · cited 1×
“…cells neither increases A clearance through brain-to-blood transportation and endogenous degradation nor reduces amyloidogenic APP metabolism Deane et al. (2004) reported that altered communication of A between the brain interstitial fluid and the peripheral bloodstream affects cerebral A…”
BackgroundKaltschmidt, B., & Kaltschmidt, C. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001271 · Cited by 392
He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390
Sheng, J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00069-x · Cited by 388 · cited 2×
“This observation was surprising in light of the fact that neuroinflammation has been reported to change -secretase and -secretase expression and activity (Sheng et al., 2003; He et al., 2007; Xie et al., 2013) and to alter the A transporter function in the blood– brain barrier (Erickson et al.”
BackgroundMicroglial activation and amyloid deposition in mild cognitive impairment: A PET study
Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367 · cited 1×
“Positron emission tomography studies have shown that microglial activation correlates with disease progression in AD patients (Cagnin et al., 2001; Edison et al., 2008; Okello et al., 2009).”
BackgroundMildner, A., Schlevogt, B., Kierdorf, K., Böttcher, C., Erny, D., Kummer, M. P., Quinn, M., Brück, W., Bechmann, I., Heneka, M. T., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6209-10.2011 · Cited by 351 · cited 6×
“We wondered whether peripheral myeloid cells had migrated into the brain and affected brain pathology in our APP mice, although one published study found a negative answer to this question (Mildner et al., 2011).”
BackgroundInfluentialMizutani, M., Pino, P. A., Saederup, N., Charo, I. F., Ransohoff, R. M., & Cardona, A. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100421 · Cited by 346 · cited 2×
“The results of this experiment provide evidence for the limited infiltration of brain macrophages in AD mice, given that brain macrophages are derived from Ly6C CCR2 monocytes (Mildner et al., 2007; Mizutani et al., 2012; Varvel et al., 2012).”
ResultYamanaka, M., Ishikawa, T., Griep, A., Axt, D., Kummer, M. P., & Heneka, M. T. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1569-12.2012 · Cited by 326 · cited 2×
“…ligand (Tan et al., 1999 and 2002), IRAK4 (Cameron et al., 2012), NLRP3 (Heneka et al., 2013), or Mrp14 (a neuroinflammation-amplifying protein; Kummer et al., 2012), by blocking TGF- -SMAD2/3 signaling (Town et al., 2008), or by stimulating PPAR and retinoid X receptors (Yamanaka et al., 2012).”
BackgroundSong, M., Jin, J., Lim, J.-E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H.-D., Tahara, K., Lalonde, R., & Fukuchi, K.-I. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-92 · Cited by 273 · cited 7×
“Microglial activation exerts both toxic and protective effects on neurons in AD pathogenesis, and TLRs and their downstream signaling molecules have been observed to control microglial behaviors that lead to these controversial effects (Tahara et al., 2006; Reed-Geaghan et al., 2010; Hao et al., 2011; Lim et al., 2011…”
BackgroundInfluentialRole of CD40 ligand in amyloidosis in transgenic Alzheimer's mice
Tan, J., Town, T., Crawford, F., Mori, T., DelleDonne, A., Crescentini, R., Obregon, D., Flavell, R. A., & Mullan, M. J. (2002) · Nature Neuroscience · doi:10.1038/nn968 · Cited by 217
Frenkel, D., Wilkinson, K., Zhao, L., Hickman, S. E., Means, T. K., Puckett, L., Farfara, D., Kingery, N. D., Weiner, H. L., & El Khoury, J. (2013) · Nature Communications · doi:10.1038/ncomms3030 · Cited by 214 · cited 1×
“IKK deficiency significantly upregulated the transcription of A -cleaning scavenger receptor A (Frenkel et al., 2013) in the brains of APPtransgenic mice, but not in the brains of their non-APPtransgenic littermates (Fig.”
BackgroundChung, H., Brazil, M. I., Soe, T. T., & Maxfield, F. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32301 · Cited by 212
Fridmacher, V., Kaltschmidt, B., Goudeau, B., Ndiaye, D., Rossi, F. M., Pfeiffer, J., Kaltschmidt, C., Israël, A., & Mémet, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09403.2003 · Cited by 167 · cited 1×
“Neuronal IKK has been reported to activate neuronal NF- B, thus modifying A generation and the degeneration and plasticity of neurons (Kaltschmidt et al., 1997; Fridmacher et al., 2003; He et al., 2007; Kaltschmidt and Kaltschmidt, 2009; Gutierrez and Davies, 2011).”
BackgroundErickson, M. A., Hartvigson, P. E., Morofuji, Y., Owen, J. B., Butterfield, D. A., & Banks, W. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-150 · Cited by 145 · cited 1×
“…observation was surprising in light of the fact that neuroinflammation has been reported to change -secretase and -secretase expression and activity (Sheng et al., 2003; He et al., 2007; Xie et al., 2013) and to alter the A transporter function in the blood– brain barrier (Erickson et al., 2012).”
BackgroundYamamoto, M., Kiyota, T., Walsh, S. M., Liu, J., Kipnis, J., & Ikezu, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3877 · Cited by 100 · cited 1×
“This difference could be due to the difference in the efficiency of degradation and extracellular release between A oligomers and fibrils in microglia (Chung et al., 1999; Yamamoto et al., 2008).”
BackgroundMyD88 Deficiency Ameliorates β-Amyloidosis in an Animal Model of Alzheimer's Disease
Lim, J.-E., Kou, J., Song, M., Pattanayak, A., Jin, J., Lalonde, R., & Fukuchi, K.-I. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.045 · Cited by 63 · cited 3×
“…in MyD88 or its downstream signaling molecule, IRAK4, attenuates A pathology and neuronal damage in APP-transgenic mice (Hao et al., 2011; Lim et al., 2011; Cameron et al., 2012), but other reports state that wildtype MyD88 is necessary for clearing A from the brain and protecting…”
BackgroundMichaud, J.-P., Richard, K. L., & Rivest, S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-5 · Cited by 48 · cited 2×
“…molecule, IRAK4, attenuates A pathology and neuronal damage in APP-transgenic mice (Hao et al., 2011; Lim et al., 2011; Cameron et al., 2012), but other reports state that wildtype MyD88 is necessary for clearing A from the brain and protecting cognitive function (Michaud et al., 2011 and 2012).”
Background
Cited by
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
Musiek, E. S., & Holtzman, D. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4018 · Cited by 662
Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532
Liu, X., Hao, W., Qin, Y., Decker, Y., Wang, X., Burkart, M., Schötz, K., Menger, M. D., Fassbender, K., & Liu, Y. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.011 · Cited by 149
Qin, Y., Liu, Y., Hao, W., Decker, Y., Tomic, I., Menger, M. D., Liu, C., & Fassbender, K. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600873 · Cited by 90
“To establish mice with modified inflammatory activation specifically in myeloid cells, we cross-bred ikbkb (24), MyD88 (25), or p38a (26) mice with LysM-Cre knock-in mice expressing Cre from the endogenous lysozyme 2 gene locus (27) as we did previously (9).”
MethodSelf-citationSignaling pathways regulating neuron–glia interaction and their implications in Alzheimer's disease
Lian, H., & Zheng, H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13424 · Cited by 77
Metadata
- Authors
- Liu, Y., Liu, X., Hao, W., Decker, Y., Schomburg, R., Fülöp, L., Pasparakis, M., Menger, M. D., & Fassbender, K.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2014-09-24
- Volume
- 34
- Issue
- 39
- Pages
- 12982-12999
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1999752943
- Cited by
- 46
- References
- 38
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.